IFNs generally act as negative regulators of collagen synthesis and TGF-β-mediated fibrotic responses, while the mechanism of type I IFN signaling in SSc-promoted fibrosis remains unclear (37, 57). Here, TGFB1 is linked to systemic sclerosis.